NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹225 Cr | ₹137 Cr | ₹64 Cr | ₹130 Cr | ₹223 Cr |
What is the latest Capital Work in Progress ratio of NATCO PHARMA ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹225 Cr |
| Mar2024 | ₹137 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹130 Cr |
| Mar2021 | ₹223 Cr |
How is Capital Work in Progress of NATCO PHARMA Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹225 Cr | 64.17 | |
| Mar2024 | ₹137 Cr | 113.53 | |
| Mar2023 | ₹64 Cr | -50.35 | |
| Mar2022 | ₹130 Cr | -42.03 | |
| Mar2021 | ₹223 Cr | - | |
Compare Capital Work in Progress of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹15,402.6 Cr | -3.4% | -6.7% | -26.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -3.4% |
-6.7% |
-26.4% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses